Intermittent high-dose oral 1,25-dihydroxyvitaimin D3 for secondary hyperparathyroidism in hemodialysis patients

This publication has 13 references indexed in Scilit:

• Parathyroidectomy in Chronic Renal Failure: a Nine-year Follow-up Study
  QJM: An International Journal of Medicine, 1990
• Long-term effects of calcium carbonate and 2.5 mEq/liter calcium dialysate on mineral metabolism
  Kidney International, 1989
• Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal Failure
  New England Journal of Medicine, 1989
• 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia
  Kidney International, 1989
• Pharmacological Parathyroidectomy by Oral 1,25(OH)2D3 Pulse Therapy
  Nephron, 1989
• 1,25(OH)2D3 Receptors and endorgan response in experimental aluminium intoxication
  Kidney International, 1987
• Reduced Binding of [³H]l,25-Dihydroxyvitamin D₃in the Parathyroid Glands of Patients with Renal Failure
  New England Journal of Medicine, 1987
• Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
  Journal of Clinical Investigation, 1984
• Parathyroid hormone: biochemical aspects of biosynthesis, secretion, action, and metabolism.
  Physiological Reviews, 1984
• Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol.
  Journal of Clinical Investigation, 1975